×
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.51 (+3.29%)
MSFT   270.75 (+1.82%)
FB   193.80 (+1.13%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.30 (+2.01%)
TSLA   751.51 (+6.19%)
NVDA   185.89 (+4.13%)
BABA   93.24 (-1.31%)
NIO   16.44 (+2.56%)
AMD   101.19 (+2.47%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.85 (+1.09%)
F   13.58 (+3.51%)
DIS   108.34 (+2.58%)
AMC   13.89 (+13.57%)
PFE   53.57 (-0.78%)
PYPL   84.95 (+5.63%)
NFLX   194.11 (+1.42%)
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.51 (+3.29%)
MSFT   270.75 (+1.82%)
FB   193.80 (+1.13%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.30 (+2.01%)
TSLA   751.51 (+6.19%)
NVDA   185.89 (+4.13%)
BABA   93.24 (-1.31%)
NIO   16.44 (+2.56%)
AMD   101.19 (+2.47%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.85 (+1.09%)
F   13.58 (+3.51%)
DIS   108.34 (+2.58%)
AMC   13.89 (+13.57%)
PFE   53.57 (-0.78%)
PYPL   84.95 (+5.63%)
NFLX   194.11 (+1.42%)
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.51 (+3.29%)
MSFT   270.75 (+1.82%)
FB   193.80 (+1.13%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.30 (+2.01%)
TSLA   751.51 (+6.19%)
NVDA   185.89 (+4.13%)
BABA   93.24 (-1.31%)
NIO   16.44 (+2.56%)
AMD   101.19 (+2.47%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.85 (+1.09%)
F   13.58 (+3.51%)
DIS   108.34 (+2.58%)
AMC   13.89 (+13.57%)
PFE   53.57 (-0.78%)
PYPL   84.95 (+5.63%)
NFLX   194.11 (+1.42%)
S&P 500   4,131.20 (+1.81%)
DOW   32,991.92 (+1.09%)
QQQ   306.91 (+2.53%)
AAPL   148.51 (+3.29%)
MSFT   270.75 (+1.82%)
FB   193.80 (+1.13%)
GOOGL   2,229.79 (+3.43%)
AMZN   2,266.30 (+2.01%)
TSLA   751.51 (+6.19%)
NVDA   185.89 (+4.13%)
BABA   93.24 (-1.31%)
NIO   16.44 (+2.56%)
AMD   101.19 (+2.47%)
CGC   4.88 (-12.07%)
MU   73.02 (+3.43%)
T   21.22 (-0.47%)
GE   77.85 (+1.09%)
F   13.58 (+3.51%)
DIS   108.34 (+2.58%)
AMC   13.89 (+13.57%)
PFE   53.57 (-0.78%)
PYPL   84.95 (+5.63%)
NFLX   194.11 (+1.42%)
LON:ODX

Omega Diagnostics Group (ODX) Share Forecast, Price & News

GBX 3.74
-0.06 (-1.58%)
(As of 05/27/2022 03:18 PM ET)
Add
Compare
Today's Range
3.61
3.80
50-Day Range
3.31
5.60
52-Week Range
3.01
78
Volume
239,056 shs
Average Volume
5.26 million shs
Market Capitalization
£6.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive ODX News and Ratings via Email

Sign-up to receive the latest news and ratings for Omega Diagnostics Group and its competitors with MarketBeat's FREE daily newsletter.

Omega Diagnostics Group logo

About Omega Diagnostics Group

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company operates through two segments, Health and Nutrition, and Global Health and Other. The Health and Nutrition segment engages in the research, development, and production of kits to aid the detection of immune reactions to food under the Foodprint name. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The Global Health and Other segment engages in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. This segment offers VISITECT CD4, an advanced disease rapid test, which is used to treat patients with HIV; and AbC-19, a COVID-19 antibody testing kit, as well as COVID-19 antigen and antibody testing solutions. The company offers its products to hospitals, clinics, laboratories, and healthcare practitioners through distributors in approximately 75 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.

Headlines

DeepVerge reports record quarter for environmental division
See More Headlines

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
171
Year Founded
N/A

Sales & Book Value

Annual Sales
£11.30 million
Cash Flow
GBX 2.56 per share
Book Value
GBX 11.30 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£6.83 million
Optionable
Not Optionable

Company Calendar

Today
5/27/2022
Next Earnings (Estimated)
7/11/2022

MarketRank

Overall MarketRank

0.76 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Omega Diagnostics Group (LON:ODX) Frequently Asked Questions

When is Omega Diagnostics Group's next earnings date?

Omega Diagnostics Group is scheduled to release its next quarterly earnings announcement on Monday, July 11th 2022.
View our earnings forecast for Omega Diagnostics Group
.

Who are Omega Diagnostics Group's key executives?
Omega Diagnostics Group's management team includes the following people:
  • Mr. Jagdeep Grewal, CEO, MD of the Health & Nutrition Division and Exec. Director (Age 53, Pay $154.69k)
  • Mr. Christopher Paul Lea, CFO, Company Sec. & Director (Age 55)
  • Mr. Iain Logan, Group Financial Controller
  • Mr. Prashant Maniar, Managing Director of Omega Dx Asia Pvt Limited
  • Mr. Andrew William Shepherd, Global Ambassador - Life Pres (Age 66)
What other stocks do shareholders of Omega Diagnostics Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Diagnostics Group investors own include CAP-XX (CPX), NVIDIA (NVDA), Tiziana Life Sciences (TILS), Velocys (VLS), Advanced Micro Devices (AMD), (APHA), COSCO SHIPPING (CICOF), Co-Diagnostics (CODX), 4D pharma (DDDD) and Datadog (DDOG).

What is Omega Diagnostics Group's stock symbol?

Omega Diagnostics Group trades on the London Stock Exchange (LON) under the ticker symbol "ODX."

How do I buy shares of Omega Diagnostics Group?

Shares of ODX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Omega Diagnostics Group's stock price today?

One share of ODX stock can currently be purchased for approximately GBX 3.74.

How much money does Omega Diagnostics Group make?

Omega Diagnostics Group has a market capitalization of £6.83 million and generates £11.30 million in revenue each year.

How many employees does Omega Diagnostics Group have?

Omega Diagnostics Group employs 171 workers across the globe.

What is Omega Diagnostics Group's official website?

The official website for Omega Diagnostics Group is www.omegadiagnostics.com.

How can I contact Omega Diagnostics Group?

Omega Diagnostics Group's mailing address is Hillfoots Business Village Alva Industrial Estate, ALVA, FK12 5DQ, United Kingdom. The company can be reached via phone at +44-1259-763030.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.